Sirona Biochem Corp V.SBM

Could it be TFC-1067...?

[24minus7]

https://www.researchgate.net/publication/375626414_Aesthetic_Efficacy_of_a_Novel_Topical_Combination_Brightening_Regimen_to_Treat_Facial_Hyperpigmentation

[LakeOromocto]

I believe it is. Question is how much longer to market??

[Pandora]

After a 12 week trial those are some pretty impressive ratings. It seems like if it is TFC-1067 it could finally open some doors.

[lscfa]

Sounds like Even & Correct which has no Sirona inside. https://www.prnewswire.com/news-releases/skinmedica-launches-even--correct-301721744.html

[LakeOromocto]

Why would they keep doing trials on a product already on the market? It can't be even and correct.

[noclue80]

it's a study re a regimen consisting of EC brightening Pads and EC serum, and once-daily evening use of EC spot cream. The Even&Correct description... You can use the three products featured in this collection—a daily serum, treatment pads and dark spot cream—separately or together to customize your hyperpigmentation treatment. why would they do a study on a completely similar product

[biorun]

It's quite possible that all three products contain 1067, or more and these tests, if they do contain our "novel ingredient", demonstrate yet again the science hits it out of the park. Makino has been pursuing 1067 since Allergan joined AbbVie. Anyone who has looked at the long list of research shows she has been trying to figure out how to get to this point. She is science side

[forhandlaren]

Would be great if Next Gen Even & Correct would be launched. The product line has alteady gained market penetration and should be able to expand based on excellent performance with TFC1067. In short - a jump start in sales. Profitable from day 1! Even & Correct was launched in January, why not Next Gen this January as well?!

[biorun]

Unlike the first Rodan agreement where customers have to try a diluted version of the formula and sales started from zero, the Allergan agreement would produce immediate existing volumes on day 1.  That means revenue should go to at least pre launch levels the very next day, then royalties to Sirona. Since it appears they are testing this from all angles, they are very likely ensuring a

[Turtle4]

Allergan's "other aesthetics" profit has fallen, not risen, since the even and correct launch. Take a look at abbvie's quarterly reports.

[Turtle4]

Because Howie wanted a high royalty. So it makes sense for Allergan to have brightening products without tfc1067, which then bring significantly more margin.

[lscfa]

Target Pathways in the Melanin Life Cycle and Key Ingredients in Dark Spot Treatment Melanin Life Cycle Pathway Dark Spot Treatment Ingredients Melanocyte activation Tranexamic acid Niacinamide Vitamin C (tetrahexyldecyl ascorbate) Melanosome development Lotus sprout